PRCT logo

PROCEPT BioRobotics Corporation (PRCT)

$20.41

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PRCT

Market cap

$1.17B

EPS

-1.95

P/E ratio

--

Price to sales

3.56

Dividend yield

--

Beta

0.885895

Price on PRCT

Previous close

$20.03

Today's open

$20.04

Day's range

$19.77 - $21.26

52 week range

$16.67 - $42.71

Profile about PRCT

CEO

Larry Wood

Employees

888

Headquarters

San Jose, CA

Exchange

NASDAQ Global Market

Shares outstanding

57273659

Issue type

Common Stock

PRCT industries and sectors

Healthcare

Medical Equipment & Supplies

News on PRCT

PRCT Deadline Alert: The Gross Law Firm Reminds PROCEPT BioRobotics Corporation (PRCT) Investors of Securities Class Action Deadline on September 22, 2026

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT).

news source

GlobeNewsWire • Aug 7, 2026

news preview

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (“PROCEPT” or the “Company”) (NASDAQ: PRCT) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in PROCEPT and have suffered losses, you may CLICK HERE to contact us.

news source

GlobeNewsWire • Aug 7, 2026

news preview

PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

NEW ORLEANS, Aug. 07, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) (“Procept” or the “Company”), if they purchased the Company's shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

news source

GlobeNewsWire • Aug 7, 2026

news preview

$PRCT Court News: PROCEPT BioRobotics Securities Fraud Class Action Deadline is Imminent – Contact BFA Law before September 22

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ:PRCT) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from potential violations of the federal securities laws. If you invested in Procept, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/procept-biorobotics-class-action-lawsuit.

news source

GlobeNewsWire • Aug 7, 2026

news preview

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PROCEPT BioRobotics Corporation (“Procept” or “the Company”) (NASDAQ: PRCT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of PRCT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

news source

GlobeNewsWire • Aug 7, 2026

news preview

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

SAN FRANCISCO, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts. The lawsuit seeks to represent investors who purchased or otherwise acquired PROCEPT common stock between February 28, 2024 and February 25, 2026.

news source

GlobeNewsWire • 21 hours ago

news preview

Kaplan Fox Reminds PROCEPT BioRobotics Corporation (PRCT) Investors of an Approaching Securities Class Action Deadline on September 22, 2026

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation ("PROCEPT" or the "Company") (NASDAQ: PRCT) on behalf of all purchasers of PROCEPT common stock between February 28, 2024 and February 25, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in PROCEPT and have suffered losses, you may CLICK HERE to contact us.

news source

Newsfile Corp • a day ago

news preview

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRCT

New York, New York--(Newsfile Corp. - August 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased PROCEPT common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

news source

Newsfile Corp • 21 hours ago

news preview

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NASDAQ: PRCT), if they purchased the Company's shares between February 28, 2024 and February 25, 2026, inclusive (the "Class Period").

news source

Newsfile Corp • 21 hours ago

news preview

PRCT Deadline Alert: SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION (PRCT) Investors of Securities Class Action Deadline on September 22, 2026

PRCT SEC disclosure adequacy securities allegations focus on whether PROCEPT BioRobotics Corporation's regulatory filings and public risk language adequately warned investors about alleged discount-driven handpiece inventory buildup before shares lost more than 75% from their Class Period high. NEW YORK, Aug. 6, 2026 /PRNewswire/ --SueWallSt notifies investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed on behalf of shareholders who purchased PROCEPT securities between February 28, 2024 and February 25, 2026.

news source

PRNewsWire • Aug 6, 2026

news preview

¹ Disclosures

Get started with M1

Invest in PROCEPT BioRobotics Corporation

Open an M1 investment account to buy and sell PROCEPT BioRobotics Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PRCT on M1